Fortress Biotech, Inc. Operating Leases, Rent Expense, Sublease Rentals
Fortress Biotech, Inc. (FBIO) reported Operating Leases, Rent Expense, Sublease Rentals of $100.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2014-11-06
- Fortress Biotech, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-09-30 was $0.00.
- Fortress Biotech, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-06-30 was $0.00.
- Fortress Biotech, Inc. operating leases, rent expense, sublease rentals for the quarter ending 2014-03-31 was $100.00K.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 9 month |
|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $100.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $100.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $100.00K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |